NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

10 hedge funds and large institutions have $304K invested in Northwest Biotherapeutics, Inc. Common stock in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
10
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MWM
1
Maripau Wealth Management
Indiana
$20.5K
2
EFG
2
Ethos Financial Group
Pennsylvania
$12K
3
MSAM
3
Moloney Securities Asset Management
Missouri
$197K
4
AA
4
AlphaMark Advisors
Kentucky
$7K

Top Sellers

1
BCWM
1
Bartlett & Co Wealth Management
Ohio
$0
2
WJWM
2
Williams Jones Wealth Management
New York
$20.8K
Name Market Value Shares Shares
Change 		Shares
Change %
MSAM
1
Moloney Securities Asset Management
Missouri
$197K 379,460 +21,300 +6%
OCG
2
Opus Capital Group
Ohio
$31K 60,150 – –
WJWM
3
Williams Jones Wealth Management
New York
$20.8K 40,000 -4,000 -9%
MWM
4
Maripau Wealth Management
Indiana
$20.5K 39,493 +39,493 New
EFG
5
Ethos Financial Group
Pennsylvania
$12K 23,700 +23,700 New
MCM
6
MAI Capital Management
Ohio
$10.4K 20,000 – –
AA
7
AlphaMark Advisors
Kentucky
$7K 14,007 +14,007 New
AMG
8
Advisors Management Group
Wisconsin
$5K 10,270 – –
BCWM
9
Bartlett & Co Wealth Management
Ohio
– – -4,292 Closed
HFS
10
Hantz Financial Services
Michigan
$0 250 – –
CMP
11
Coston McIsaac & Partners
Maine
$0 1,000 – –